ResMed Inc.
RSMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,335,582 | $1,347,993 | $1,291,736 | $1,282,089 |
| % Growth | -0.9% | 4.4% | 0.8% | – |
| Cost of Goods Sold | $514,762 | $527,923 | $525,328 | $530,814 |
| Gross Profit | $820,820 | $820,070 | $766,408 | $751,275 |
| % Margin | 61.5% | 60.8% | 59.3% | 58.6% |
| R&D Expenses | $87,323 | $86,443 | $83,944 | $81,373 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $259,194 | $265,125 | $245,302 | $241,613 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $27,766 | $13,959 | $10,893 | $11,047 |
| Operating Expenses | $374,283 | $365,527 | $340,139 | $334,033 |
| Operating Income | $446,537 | $454,540 | $426,268 | $417,243 |
| % Margin | 33.4% | 33.7% | 33% | 32.5% |
| Other Income/Exp. Net | $256 | $3,513 | -$8,575 | $1,079 |
| Pre-Tax Income | $446,793 | $458,053 | $417,693 | $418,322 |
| Tax Expense | $98,257 | $78,348 | $52,652 | $73,700 |
| Net Income | $348,536 | $379,705 | $365,041 | $344,622 |
| % Margin | 26.1% | 28.2% | 28.3% | 26.9% |
| EPS | 2.38 | 2.59 | 2.49 | 2.35 |
| % Growth | -8.1% | 4% | 6% | – |
| EPS Diluted | 2.37 | 2.58 | 2.48 | 2.34 |
| Weighted Avg Shares Out | 146,472 | 146,472 | 146,719 | 146,861 |
| Weighted Avg Shares Out Dil | 147,037 | 147,037 | 147,220 | 147,599 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $5,757 | $793 | $0 |
| Interest Expense | $8,793 | $0 | $0 | $4,788 |
| Depreciation & Amortization | $47,698 | $74,288 | $51,910 | $55,902 |
| EBITDA | $503,284 | $532,341 | $469,603 | $479,012 |
| % Margin | 37.7% | 39.5% | 36.4% | 37.4% |